09:53:32 EST Tue 02 Dec 2025
Enter Symbol
or Name
USA
CA



Q:NEO - NEOGENOMICS INC - https://www.neogenomics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NEO - Q0.311.93·12.110.112.005-0.015-0.1138.189131112.07  12.07  11.9719.115  4.7209:33:00Nov 0615 min RT 2¢

Recent Trades - Last 10 of 311
Time ETExPriceChangeVolume
09:33:00Q12.02 32
09:33:00Q12.02 32
09:32:21Q12.0250.00510
09:32:21Q12.0250.00532
09:32:21Q12.0250.00532
09:32:21Q12.0250.00532
09:32:21Q12.0250.00532
09:32:15Q12.0250.00532
09:32:15Q12.0250.00532
09:32:06Q12.005-0.015100

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-11-06 07:05U:NEONews ReleaseNeoGenomics to Participate in Upcoming Investor Conferences
2025-10-30 12:51U:NEONews ReleaseNeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors
2025-10-28 07:05U:NEONews ReleaseNeoGenomics Reports Third Quarter 2025 Results
2025-10-14 07:05U:NEONews ReleaseNeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025
2025-10-07 07:05U:NEONews ReleaseNeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025
2025-08-29 07:05U:NEONews ReleaseCourt Rules for NeoGenomics in Patent Infringement Lawsuit Against Natera
2025-07-30 07:05U:NEONews ReleaseNeoGenomics Launches PanTracer LBx, Expanding Access to Comprehensive Genomic Profiling with Liquid Biopsy
2025-07-29 07:05U:NEONews ReleaseNeoGenomics Reports Second Quarter 2025 Results
2025-07-01 07:05U:NEONews ReleaseNeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025
2025-06-30 07:05U:NEONews ReleaseNeoGenomics Announces PanTracer Tissue and PanTracer Tissue + HRD Now Available to Support More Informed and Timely Cancer Care
2025-06-24 07:05U:NEONews ReleaseNeoGenomics Appoints Dr. Marjorie Green to Board of Directors
2025-05-28 07:10U:NEONews ReleaseNeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025
2025-05-22 07:10U:NEONews ReleaseNeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung Cancer
2025-05-20 07:05U:NEONews ReleaseNeoGenomics to Participate in Upcoming June Investor Conferences
2025-05-01 07:05U:NEONews ReleaseNeoGenomics Pays Off 1.25% Convertible Senior Notes
2025-04-29 08:00U:NEONews ReleaseNeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform
2025-04-29 07:30U:NEONews ReleaseNeoGenomics Reports First Quarter 2025 Results
2025-04-22 07:05U:NEONews ReleaseNeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual Meeting
2025-04-08 07:05U:NEONews ReleaseNeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025
2025-04-07 07:05U:NEONews ReleaseNeoGenomics Completes Acquisition of Pathline